...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Age, MoCA and CKD
8
Nov 18, 2019 05:52PM
6
Nov 18, 2019 06:00PM
2
Nov 18, 2019 06:09PM
4
Nov 18, 2019 06:44PM
1
Nov 18, 2019 07:29PM
3
Nov 18, 2019 08:00PM
2
Nov 19, 2019 08:42AM
2
Nov 19, 2019 09:01AM
1
Nov 19, 2019 09:05AM
3
Nov 19, 2019 09:19AM
2
Nov 19, 2019 11:24AM
3
Nov 19, 2019 02:51PM
5
Nov 19, 2019 02:59PM
6
Nov 19, 2019 03:15PM
5
Dec 06, 2019 12:24PM
  • A problem I gave in assessing the reliability of the prespecified subgroup data analyses (all of them) is that Don has never to my knowledge shown how well (or how poorly) the placebo and treated patients within the subgroups were matched for relevant variables. Given that they knew in advance what subgroup analyses they were going to do, ideally they should have used a stratified randomisation procedure to ensure that the subgroups (not just the total groups) would be well matched for the things that matter. As it is, they left that to chance, and we don’t know how it worked it out. 
2
Dec 06, 2019 01:14PM
1
Dec 06, 2019 01:16PM
1
Dec 06, 2019 01:26PM

Dec 06, 2019 01:32PM
2
Dec 06, 2019 01:49PM
3
Dec 06, 2019 02:58PM
Share
New Message
Please login to post a reply